Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis
IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative condition primarily involving the motor system. There is increasing epidemiologic evidence of an association between ALS and a wider spectrum of neurodegenerative and neuropsychiatric disorders among family members, i...
Gespeichert in:
Veröffentlicht in: | JAMA neurology 2017-12, Vol.74 (12), p.1425-1430 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1430 |
---|---|
container_issue | 12 |
container_start_page | 1425 |
container_title | JAMA neurology |
container_volume | 74 |
creator | O’Brien, Margaret Burke, Tom Heverin, Mark Vajda, Alice McLaughlin, Russell Gibbons, John Byrne, Susan Pinto-Grau, Marta Elamin, Marwa Pender, Niall Hardiman, Orla |
description | IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative condition primarily involving the motor system. There is increasing epidemiologic evidence of an association between ALS and a wider spectrum of neurodegenerative and neuropsychiatric disorders among family members, including schizophrenia and psychotic illness and suicidal behavior. OBJECTIVE: To examine the frequency and range of neuropsychiatric conditions that occur within individual first-degree and second-degree relatives of patients with ALS. DESIGN, SETTING, AND PARTICIPANTS: In this population-based, case-control family aggregation study, all 202 patients included in the Irish ALS Register between January 1, 2012, and January 31, 2014, with definite, probable, or possible ALS as defined by El Escorial criteria were invited to participate. A total of 75 patients were unable or refused to participate and were excluded; the remaining 127 patients with incident ALS were genotyped for the C9orf72 repeat expansion and 132 age- and sex-matched controls were included in the study. MAIN OUTCOME AND MEASURES: The prevalence of defined neuropsychiatric disease in first-degree and second-degree relatives of patients with ALS and matched controls was determined. RESULTS: Mean (SD) age at diagnosis of the 127 patients in the study (58 women and 69 men) was 64.2 (10.7) years. Data from 2116 relatives of patients with ALS were reported, including 924 first-degree relatives, 1128 second-degree relatives, and 64 third-degree relatives. Data from controls were reported from 829 first-degree and 1310 second-degree relatives. A total of 77 patients with ALS (61.4%) and 51 control participants (38.6%) reported at least 1 first-degree or second-degree relative with a history of schizophrenia, psychosis, suicide, depression, alcoholism, or autism (relative risk [RR], 1.50; 95% CI, 1.08-2.17; P = .02). Cluster analysis suggested the following 2 subgroups based on the number of family members with a neuropsychiatric condition: expected (0-2) and high (≥3). Within the high subgroup, ALS kindreds presented a significantly higher rate of psychiatric illness than did controls (28 of 39 [71.8%]; mean [SD] number of siblings, 4.29 [1.41]; P = .001). A strong family history of schizophrenia (RR, 3.40; 95% CI, 1.27-9.30; P = .02), suicide (RR, 3.30; 95% CI, 1.07-10.05; P = .04), autism (RR, 10.10; 95% CI, 1.30-78.80; P = .03), and alcoholism (RR, 1.48; 95% CI, 1.01-2.17; P = .045) was reported in AL |
doi_str_mv | 10.1001/jamaneurol.2017.2699 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5822189</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2657325</ama_id><sourcerecordid>29049464</sourcerecordid><originalsourceid>FETCH-LOGICAL-a427t-2d50d1d168b829a0a3084b66c867c27db597410d1dab857b69c232792f37113</originalsourceid><addsrcrecordid>eNpVkdFKwzAUhoMobsy9gIjkBTqTNE2aG2FMp8JQcYKXIU3TNaNrR9INdumbmzK3aW5yyDn_d_7wA3CD0QgjhO-WaqVqs3FNNSII8xFhQpyBPsEsjRhO-PmxpqIHht4vUTgpQjSml6BHBKKCMtoH35Nq41vjbL2ATQFfO-ba73RpVeushg_WG-UNtDWcWufb6MEsnDFQ1TmcG93U-eHlw1SqtVvjO857KE3devhl2xKOV7umDdwyAGcqbFMVnOvKuMZbfwUuClV5M_y9B2A-ffycPEezt6eXyXgWKUp4G5E8QTnOw6eylAiFVIxSmjGmU8Y14XmWCE5xN6KyNOEZE5rEhAtSxBzjeADu99T1JluZXAdzwYVcO7tSbicbZeX_Tm1LuWi2MkkJwakIALoH6ODaO1MctRjJLhN5ykR2mcgukyC7_bv3KDokEAau9wNBfeqyhMckiX8A9QuWTg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>O’Brien, Margaret ; Burke, Tom ; Heverin, Mark ; Vajda, Alice ; McLaughlin, Russell ; Gibbons, John ; Byrne, Susan ; Pinto-Grau, Marta ; Elamin, Marwa ; Pender, Niall ; Hardiman, Orla</creator><creatorcontrib>O’Brien, Margaret ; Burke, Tom ; Heverin, Mark ; Vajda, Alice ; McLaughlin, Russell ; Gibbons, John ; Byrne, Susan ; Pinto-Grau, Marta ; Elamin, Marwa ; Pender, Niall ; Hardiman, Orla</creatorcontrib><description>IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative condition primarily involving the motor system. There is increasing epidemiologic evidence of an association between ALS and a wider spectrum of neurodegenerative and neuropsychiatric disorders among family members, including schizophrenia and psychotic illness and suicidal behavior. OBJECTIVE: To examine the frequency and range of neuropsychiatric conditions that occur within individual first-degree and second-degree relatives of patients with ALS. DESIGN, SETTING, AND PARTICIPANTS: In this population-based, case-control family aggregation study, all 202 patients included in the Irish ALS Register between January 1, 2012, and January 31, 2014, with definite, probable, or possible ALS as defined by El Escorial criteria were invited to participate. A total of 75 patients were unable or refused to participate and were excluded; the remaining 127 patients with incident ALS were genotyped for the C9orf72 repeat expansion and 132 age- and sex-matched controls were included in the study. MAIN OUTCOME AND MEASURES: The prevalence of defined neuropsychiatric disease in first-degree and second-degree relatives of patients with ALS and matched controls was determined. RESULTS: Mean (SD) age at diagnosis of the 127 patients in the study (58 women and 69 men) was 64.2 (10.7) years. Data from 2116 relatives of patients with ALS were reported, including 924 first-degree relatives, 1128 second-degree relatives, and 64 third-degree relatives. Data from controls were reported from 829 first-degree and 1310 second-degree relatives. A total of 77 patients with ALS (61.4%) and 51 control participants (38.6%) reported at least 1 first-degree or second-degree relative with a history of schizophrenia, psychosis, suicide, depression, alcoholism, or autism (relative risk [RR], 1.50; 95% CI, 1.08-2.17; P = .02). Cluster analysis suggested the following 2 subgroups based on the number of family members with a neuropsychiatric condition: expected (0-2) and high (≥3). Within the high subgroup, ALS kindreds presented a significantly higher rate of psychiatric illness than did controls (28 of 39 [71.8%]; mean [SD] number of siblings, 4.29 [1.41]; P = .001). A strong family history of schizophrenia (RR, 3.40; 95% CI, 1.27-9.30; P = .02), suicide (RR, 3.30; 95% CI, 1.07-10.05; P = .04), autism (RR, 10.10; 95% CI, 1.30-78.80; P = .03), and alcoholism (RR, 1.48; 95% CI, 1.01-2.17; P = .045) was reported in ALS kindreds. A total of 5 of 29 probands (17.2%) with a strong family history of neuropsychiatric conditions (≥3 first-degree or second-degree relatives) carried the C9orf72 repeat expansion. CONCLUSIONS AND RELEVANCE: Neuropsychiatric symptoms in addition to schizophrenia, including obsessive-compulsive disorder, autism, and alcoholism, occur more frequently in ALS kindreds than in controls. The presence of the C9orf72 repeat expansion does not fully account for this finding, suggesting the presence of additional pleiotropic genes associated with both ALS and neuropsychiatric disease in the Irish population.</description><identifier>ISSN: 2168-6149</identifier><identifier>EISSN: 2168-6157</identifier><identifier>DOI: 10.1001/jamaneurol.2017.2699</identifier><identifier>PMID: 29049464</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Aged ; Alcoholism - epidemiology ; Alcoholism - genetics ; Alcoholism - psychology ; Amyotrophic Lateral Sclerosis - epidemiology ; Amyotrophic Lateral Sclerosis - genetics ; Autistic Disorder - epidemiology ; Autistic Disorder - genetics ; Autistic Disorder - psychology ; C9orf72 Protein - genetics ; Case-Control Studies ; Depressive Disorder - epidemiology ; Depressive Disorder - genetics ; Depressive Disorder - psychology ; Family - psychology ; Female ; Genetic Predisposition to Disease ; Humans ; Ireland - epidemiology ; Male ; Mental Disorders - epidemiology ; Mental Disorders - genetics ; Mental Disorders - psychology ; Middle Aged ; Online First ; Original Investigation ; Psychotic Disorders - epidemiology ; Psychotic Disorders - genetics ; Psychotic Disorders - psychology ; Risk ; Schizophrenia - epidemiology ; Schizophrenia - genetics ; Schizophrenic Psychology ; Suicide - psychology ; Suicide - statistics & numerical data</subject><ispartof>JAMA neurology, 2017-12, Vol.74 (12), p.1425-1430</ispartof><rights>Copyright 2017 American Medical Association. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a427t-2d50d1d168b829a0a3084b66c867c27db597410d1dab857b69c232792f37113</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamaneurology/articlepdf/10.1001/jamaneurol.2017.2699$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2017.2699$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,230,314,776,780,881,3327,27901,27902,76232,76235</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29049464$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O’Brien, Margaret</creatorcontrib><creatorcontrib>Burke, Tom</creatorcontrib><creatorcontrib>Heverin, Mark</creatorcontrib><creatorcontrib>Vajda, Alice</creatorcontrib><creatorcontrib>McLaughlin, Russell</creatorcontrib><creatorcontrib>Gibbons, John</creatorcontrib><creatorcontrib>Byrne, Susan</creatorcontrib><creatorcontrib>Pinto-Grau, Marta</creatorcontrib><creatorcontrib>Elamin, Marwa</creatorcontrib><creatorcontrib>Pender, Niall</creatorcontrib><creatorcontrib>Hardiman, Orla</creatorcontrib><title>Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis</title><title>JAMA neurology</title><addtitle>JAMA Neurol</addtitle><description>IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative condition primarily involving the motor system. There is increasing epidemiologic evidence of an association between ALS and a wider spectrum of neurodegenerative and neuropsychiatric disorders among family members, including schizophrenia and psychotic illness and suicidal behavior. OBJECTIVE: To examine the frequency and range of neuropsychiatric conditions that occur within individual first-degree and second-degree relatives of patients with ALS. DESIGN, SETTING, AND PARTICIPANTS: In this population-based, case-control family aggregation study, all 202 patients included in the Irish ALS Register between January 1, 2012, and January 31, 2014, with definite, probable, or possible ALS as defined by El Escorial criteria were invited to participate. A total of 75 patients were unable or refused to participate and were excluded; the remaining 127 patients with incident ALS were genotyped for the C9orf72 repeat expansion and 132 age- and sex-matched controls were included in the study. MAIN OUTCOME AND MEASURES: The prevalence of defined neuropsychiatric disease in first-degree and second-degree relatives of patients with ALS and matched controls was determined. RESULTS: Mean (SD) age at diagnosis of the 127 patients in the study (58 women and 69 men) was 64.2 (10.7) years. Data from 2116 relatives of patients with ALS were reported, including 924 first-degree relatives, 1128 second-degree relatives, and 64 third-degree relatives. Data from controls were reported from 829 first-degree and 1310 second-degree relatives. A total of 77 patients with ALS (61.4%) and 51 control participants (38.6%) reported at least 1 first-degree or second-degree relative with a history of schizophrenia, psychosis, suicide, depression, alcoholism, or autism (relative risk [RR], 1.50; 95% CI, 1.08-2.17; P = .02). Cluster analysis suggested the following 2 subgroups based on the number of family members with a neuropsychiatric condition: expected (0-2) and high (≥3). Within the high subgroup, ALS kindreds presented a significantly higher rate of psychiatric illness than did controls (28 of 39 [71.8%]; mean [SD] number of siblings, 4.29 [1.41]; P = .001). A strong family history of schizophrenia (RR, 3.40; 95% CI, 1.27-9.30; P = .02), suicide (RR, 3.30; 95% CI, 1.07-10.05; P = .04), autism (RR, 10.10; 95% CI, 1.30-78.80; P = .03), and alcoholism (RR, 1.48; 95% CI, 1.01-2.17; P = .045) was reported in ALS kindreds. A total of 5 of 29 probands (17.2%) with a strong family history of neuropsychiatric conditions (≥3 first-degree or second-degree relatives) carried the C9orf72 repeat expansion. CONCLUSIONS AND RELEVANCE: Neuropsychiatric symptoms in addition to schizophrenia, including obsessive-compulsive disorder, autism, and alcoholism, occur more frequently in ALS kindreds than in controls. The presence of the C9orf72 repeat expansion does not fully account for this finding, suggesting the presence of additional pleiotropic genes associated with both ALS and neuropsychiatric disease in the Irish population.</description><subject>Aged</subject><subject>Alcoholism - epidemiology</subject><subject>Alcoholism - genetics</subject><subject>Alcoholism - psychology</subject><subject>Amyotrophic Lateral Sclerosis - epidemiology</subject><subject>Amyotrophic Lateral Sclerosis - genetics</subject><subject>Autistic Disorder - epidemiology</subject><subject>Autistic Disorder - genetics</subject><subject>Autistic Disorder - psychology</subject><subject>C9orf72 Protein - genetics</subject><subject>Case-Control Studies</subject><subject>Depressive Disorder - epidemiology</subject><subject>Depressive Disorder - genetics</subject><subject>Depressive Disorder - psychology</subject><subject>Family - psychology</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Ireland - epidemiology</subject><subject>Male</subject><subject>Mental Disorders - epidemiology</subject><subject>Mental Disorders - genetics</subject><subject>Mental Disorders - psychology</subject><subject>Middle Aged</subject><subject>Online First</subject><subject>Original Investigation</subject><subject>Psychotic Disorders - epidemiology</subject><subject>Psychotic Disorders - genetics</subject><subject>Psychotic Disorders - psychology</subject><subject>Risk</subject><subject>Schizophrenia - epidemiology</subject><subject>Schizophrenia - genetics</subject><subject>Schizophrenic Psychology</subject><subject>Suicide - psychology</subject><subject>Suicide - statistics & numerical data</subject><issn>2168-6149</issn><issn>2168-6157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkdFKwzAUhoMobsy9gIjkBTqTNE2aG2FMp8JQcYKXIU3TNaNrR9INdumbmzK3aW5yyDn_d_7wA3CD0QgjhO-WaqVqs3FNNSII8xFhQpyBPsEsjRhO-PmxpqIHht4vUTgpQjSml6BHBKKCMtoH35Nq41vjbL2ATQFfO-ba73RpVeushg_WG-UNtDWcWufb6MEsnDFQ1TmcG93U-eHlw1SqtVvjO857KE3devhl2xKOV7umDdwyAGcqbFMVnOvKuMZbfwUuClV5M_y9B2A-ffycPEezt6eXyXgWKUp4G5E8QTnOw6eylAiFVIxSmjGmU8Y14XmWCE5xN6KyNOEZE5rEhAtSxBzjeADu99T1JluZXAdzwYVcO7tSbicbZeX_Tm1LuWi2MkkJwakIALoH6ODaO1MctRjJLhN5ykR2mcgukyC7_bv3KDokEAau9wNBfeqyhMckiX8A9QuWTg</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>O’Brien, Margaret</creator><creator>Burke, Tom</creator><creator>Heverin, Mark</creator><creator>Vajda, Alice</creator><creator>McLaughlin, Russell</creator><creator>Gibbons, John</creator><creator>Byrne, Susan</creator><creator>Pinto-Grau, Marta</creator><creator>Elamin, Marwa</creator><creator>Pender, Niall</creator><creator>Hardiman, Orla</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20171201</creationdate><title>Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis</title><author>O’Brien, Margaret ; Burke, Tom ; Heverin, Mark ; Vajda, Alice ; McLaughlin, Russell ; Gibbons, John ; Byrne, Susan ; Pinto-Grau, Marta ; Elamin, Marwa ; Pender, Niall ; Hardiman, Orla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a427t-2d50d1d168b829a0a3084b66c867c27db597410d1dab857b69c232792f37113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Alcoholism - epidemiology</topic><topic>Alcoholism - genetics</topic><topic>Alcoholism - psychology</topic><topic>Amyotrophic Lateral Sclerosis - epidemiology</topic><topic>Amyotrophic Lateral Sclerosis - genetics</topic><topic>Autistic Disorder - epidemiology</topic><topic>Autistic Disorder - genetics</topic><topic>Autistic Disorder - psychology</topic><topic>C9orf72 Protein - genetics</topic><topic>Case-Control Studies</topic><topic>Depressive Disorder - epidemiology</topic><topic>Depressive Disorder - genetics</topic><topic>Depressive Disorder - psychology</topic><topic>Family - psychology</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Ireland - epidemiology</topic><topic>Male</topic><topic>Mental Disorders - epidemiology</topic><topic>Mental Disorders - genetics</topic><topic>Mental Disorders - psychology</topic><topic>Middle Aged</topic><topic>Online First</topic><topic>Original Investigation</topic><topic>Psychotic Disorders - epidemiology</topic><topic>Psychotic Disorders - genetics</topic><topic>Psychotic Disorders - psychology</topic><topic>Risk</topic><topic>Schizophrenia - epidemiology</topic><topic>Schizophrenia - genetics</topic><topic>Schizophrenic Psychology</topic><topic>Suicide - psychology</topic><topic>Suicide - statistics & numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O’Brien, Margaret</creatorcontrib><creatorcontrib>Burke, Tom</creatorcontrib><creatorcontrib>Heverin, Mark</creatorcontrib><creatorcontrib>Vajda, Alice</creatorcontrib><creatorcontrib>McLaughlin, Russell</creatorcontrib><creatorcontrib>Gibbons, John</creatorcontrib><creatorcontrib>Byrne, Susan</creatorcontrib><creatorcontrib>Pinto-Grau, Marta</creatorcontrib><creatorcontrib>Elamin, Marwa</creatorcontrib><creatorcontrib>Pender, Niall</creatorcontrib><creatorcontrib>Hardiman, Orla</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JAMA neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O’Brien, Margaret</au><au>Burke, Tom</au><au>Heverin, Mark</au><au>Vajda, Alice</au><au>McLaughlin, Russell</au><au>Gibbons, John</au><au>Byrne, Susan</au><au>Pinto-Grau, Marta</au><au>Elamin, Marwa</au><au>Pender, Niall</au><au>Hardiman, Orla</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis</atitle><jtitle>JAMA neurology</jtitle><addtitle>JAMA Neurol</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>74</volume><issue>12</issue><spage>1425</spage><epage>1430</epage><pages>1425-1430</pages><issn>2168-6149</issn><eissn>2168-6157</eissn><abstract>IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative condition primarily involving the motor system. There is increasing epidemiologic evidence of an association between ALS and a wider spectrum of neurodegenerative and neuropsychiatric disorders among family members, including schizophrenia and psychotic illness and suicidal behavior. OBJECTIVE: To examine the frequency and range of neuropsychiatric conditions that occur within individual first-degree and second-degree relatives of patients with ALS. DESIGN, SETTING, AND PARTICIPANTS: In this population-based, case-control family aggregation study, all 202 patients included in the Irish ALS Register between January 1, 2012, and January 31, 2014, with definite, probable, or possible ALS as defined by El Escorial criteria were invited to participate. A total of 75 patients were unable or refused to participate and were excluded; the remaining 127 patients with incident ALS were genotyped for the C9orf72 repeat expansion and 132 age- and sex-matched controls were included in the study. MAIN OUTCOME AND MEASURES: The prevalence of defined neuropsychiatric disease in first-degree and second-degree relatives of patients with ALS and matched controls was determined. RESULTS: Mean (SD) age at diagnosis of the 127 patients in the study (58 women and 69 men) was 64.2 (10.7) years. Data from 2116 relatives of patients with ALS were reported, including 924 first-degree relatives, 1128 second-degree relatives, and 64 third-degree relatives. Data from controls were reported from 829 first-degree and 1310 second-degree relatives. A total of 77 patients with ALS (61.4%) and 51 control participants (38.6%) reported at least 1 first-degree or second-degree relative with a history of schizophrenia, psychosis, suicide, depression, alcoholism, or autism (relative risk [RR], 1.50; 95% CI, 1.08-2.17; P = .02). Cluster analysis suggested the following 2 subgroups based on the number of family members with a neuropsychiatric condition: expected (0-2) and high (≥3). Within the high subgroup, ALS kindreds presented a significantly higher rate of psychiatric illness than did controls (28 of 39 [71.8%]; mean [SD] number of siblings, 4.29 [1.41]; P = .001). A strong family history of schizophrenia (RR, 3.40; 95% CI, 1.27-9.30; P = .02), suicide (RR, 3.30; 95% CI, 1.07-10.05; P = .04), autism (RR, 10.10; 95% CI, 1.30-78.80; P = .03), and alcoholism (RR, 1.48; 95% CI, 1.01-2.17; P = .045) was reported in ALS kindreds. A total of 5 of 29 probands (17.2%) with a strong family history of neuropsychiatric conditions (≥3 first-degree or second-degree relatives) carried the C9orf72 repeat expansion. CONCLUSIONS AND RELEVANCE: Neuropsychiatric symptoms in addition to schizophrenia, including obsessive-compulsive disorder, autism, and alcoholism, occur more frequently in ALS kindreds than in controls. The presence of the C9orf72 repeat expansion does not fully account for this finding, suggesting the presence of additional pleiotropic genes associated with both ALS and neuropsychiatric disease in the Irish population.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>29049464</pmid><doi>10.1001/jamaneurol.2017.2699</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2168-6149 |
ispartof | JAMA neurology, 2017-12, Vol.74 (12), p.1425-1430 |
issn | 2168-6149 2168-6157 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5822189 |
source | MEDLINE; American Medical Association Journals |
subjects | Aged Alcoholism - epidemiology Alcoholism - genetics Alcoholism - psychology Amyotrophic Lateral Sclerosis - epidemiology Amyotrophic Lateral Sclerosis - genetics Autistic Disorder - epidemiology Autistic Disorder - genetics Autistic Disorder - psychology C9orf72 Protein - genetics Case-Control Studies Depressive Disorder - epidemiology Depressive Disorder - genetics Depressive Disorder - psychology Family - psychology Female Genetic Predisposition to Disease Humans Ireland - epidemiology Male Mental Disorders - epidemiology Mental Disorders - genetics Mental Disorders - psychology Middle Aged Online First Original Investigation Psychotic Disorders - epidemiology Psychotic Disorders - genetics Psychotic Disorders - psychology Risk Schizophrenia - epidemiology Schizophrenia - genetics Schizophrenic Psychology Suicide - psychology Suicide - statistics & numerical data |
title | Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T23%3A54%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clustering%20of%20Neuropsychiatric%20Disease%20in%20First-Degree%20and%20Second-Degree%20Relatives%20of%20Patients%20With%20Amyotrophic%20Lateral%20Sclerosis&rft.jtitle=JAMA%20neurology&rft.au=O%E2%80%99Brien,%20Margaret&rft.date=2017-12-01&rft.volume=74&rft.issue=12&rft.spage=1425&rft.epage=1430&rft.pages=1425-1430&rft.issn=2168-6149&rft.eissn=2168-6157&rft_id=info:doi/10.1001/jamaneurol.2017.2699&rft_dat=%3Cpubmed_cross%3E29049464%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/29049464&rft_ama_id=2657325&rfr_iscdi=true |